Is Circulating Tumor DNA Ready for Clinical Use in Large B-cell Lymphoma?

Reid W Merryman, Mark Roschewski

Open source

DOI
10.1182/blood.2026033073
Published
2026-11-10
Container
Blood Journal
Publisher
American Society of Hematology
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1182/blood.2026033073,
  title = {Is Circulating Tumor DNA Ready for Clinical Use in Large B-cell Lymphoma?},
  author = {Reid W Merryman and Mark Roschewski},
  year = {2026},
  journal = {Blood Journal},
  doi = {10.1182/blood.2026033073},
  url = {https://doi.org/10.1182/blood.2026033073}
}

RIS

TY  - JOUR
TI  - Is Circulating Tumor DNA Ready for Clinical Use in Large B-cell Lymphoma?
AU  - Reid W Merryman
AU  - Mark Roschewski
PY  - 2026
JO  - Blood Journal
DO  - 10.1182/blood.2026033073
UR  - https://doi.org/10.1182/blood.2026033073
ER  - 

APA

Merryman, R. W., & Roschewski, M. (2026). Is Circulating Tumor DNA Ready for Clinical Use in Large B-cell Lymphoma?. Blood Journal. https://doi.org/10.1182/blood.2026033073

Source records